Late Stage Capitalism

5529 readers

17 users here now

founded 5 years ago

MODERATORS

China’s new cancer drug is approved in the US but will cost 30 times more: US$280 in China, US$8,892 in the US (www.scmp.com)

submitted 9 months ago by cfgaussian@lemmygrad.ml to c/latestagecapitalism@lemmygrad.ml

15 comments fedilink hide all child comments

you are viewing a single comment's thread
view the rest of the comments

[–] WayeeCool@hexbear.net 9 points 9 months ago

Who is pocketing the price difference:

Junshi partnered with California-based Coherus BioSciences to bring the drug to the US, and it is expected to become available within the first quarter of next year.

Gotta love how the US regulatory regime is structured so middle men always get their taste. It's like how the US doesn't produce much in the way of active ingredients, instead US companies import them from China, India, and Poland then package them under their own brand name into pill, capsule, or injectable formulation. During this process the price somehow increases 1,000% to 10,000% over what they paid for the active ingredient.